BRIEF-Nextcell Reports Encouraging Numerical Results From ProTrans-Young

4

Oct 26 (Reuters) – NextCell Pharma AB: * REPORTS ENCOURAGING NUMERICAL RESULTS IN YOUNGER CHILDREN – STRATEGY FOR ADULTS REMAINS UNCHANGED * CHILDREN AGED 7-11 TREATED WITH NXTCL-T1D PRESERVED MORE

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)